Skip to main content
Premium Trial:

Request an Annual Quote

More Trouble for Thompson

Premium

Craig Thompson — CEO and president of Memorial Sloan-Kettering Cancer Center and noted cancer researcher — was accused in December of taking research that belonged to the Abramson Family Cancer Research Institute at the University of Pennsylvania, and using it to start a company focused on cancer metabolism research and the development of new treatments. The institute said Thompson stole the research and made $110 million from it, and filed suit against him for $1 billion in damages.

Now, UPenn itself has also filed suit against Thompson, saying he "failed to share intellectual property from his discoveries with the university as he was required to do," reports ScienceInsider's Eliot Marshall. "Instead, Penn claims, Thompson published his group's findings of variant cancer cell enzymes in Nature and Cancer Cell while helping a private company seek patents on the discoveries." Both lawsuits have included Agios Pharmaceuticals — the company Thompson helped found — as a defendant.

Thompson says all the allegations are without merit, and tells Marshall he is "disappointed" that Penn would make such accusations without confirming their validity with him first. An Agios spokesperson also tells Marshall that the company has done nothing wrong.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.